[Federal Register Volume 78, Number 132 (Wednesday, July 10, 2013)]
[Notices]
[Pages 41412-41413]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-16603]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission of Childhood Vaccines; Request for 
Nominations for Voting Members

AGENCY: Health Resources and Services Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Health Resources and Services Administration (HRSA) is 
requesting nominations to fill three vacancies on the Advisory 
Commission on Childhood Vaccines (ACCV). The ACCV was established by 
Title XXI of the Public Health Service Act (the Act), as enacted by 
Public Law (Pub. L.) 99-660 and as subsequently amended, and advises 
the Secretary of Health and Human Services (the Secretary) on issues 
related to implementation of the National Vaccine Injury Compensation 
Program (VICP).

DATES: The agency must receive nominations on or before August 9, 2013.

ADDRESSES: All nominations are to be submitted to the Director, 
Division of Vaccine Injury Compensation, Healthcare Systems Bureau 
(HSB), HRSA, Parklawn Building, Room 11C-26, 5600 Fishers Lane, 
Rockville, Maryland 20857.

FOR FURTHER INFORMATION CONTACT: Ms. Annie Herzog, Principal Staff 
Liaison, Division of Vaccine Injury Compensation, HSB, HRSA, at (301) 
443-6634 or email: aherzog@hrsa.gov.

SUPPLEMENTARY INFORMATION: Under the authorities that established the 
ACCV, the Federal Advisory Committee Act of October 6, 1972 (Pub. L. 
92-463) and section 2119 of the Act, 42 U.S.C. 300aa-19, as added by 
Public Law 99-660 and amended, HRSA is requesting nominations for three 
voting members of the ACCV.

[[Page 41413]]

    The ACCV advises the Secretary on the implementation of the VICP. 
The activities of the ACCV include: Recommending changes in the Vaccine 
Injury Table at its own initiative or as the result of the filing of a 
petition; advising the Secretary in implementing section 2127 regarding 
the need for childhood vaccination products that result in fewer or no 
significant adverse reactions; surveying federal, state, and local 
programs and activities related to gathering information on injuries 
associated with the administration of childhood vaccines, including the 
adverse reaction reporting requirements of section 2125(b); advising 
the Secretary on the methods of obtaining, compiling, publishing, and 
using credible data related to the frequency and severity of adverse 
reactions associated with childhood vaccines; consulting on the 
development or revision of the Vaccine Information Statements; and 
recommending to the Director of the National Vaccine Program that 
vaccine safety research be conducted on various vaccine injuries.
    The ACCV consists of nine voting members appointed by the Secretary 
as follows:
    (1) Three health professionals, who are not employees of the United 
States Government, and who have expertise in the health care of 
children, and the epidemiology, etiology, and prevention of childhood 
diseases, and the adverse reactions associated with vaccines, of whom 
at least two shall be pediatricians; (2) three members from the general 
public, of whom at least two shall be legal representatives (parents or 
guardians) of children who have suffered a vaccine related injury or 
death; and (3) three attorneys, of whom at least one shall be an 
attorney whose specialty includes representation of persons who have 
suffered a vaccine-related injury or death, and of whom one shall be an 
attorney whose specialty includes representation of vaccine 
manufacturers. In addition, the Director of the National Institutes of 
Health, the Assistant Secretary for Health, the Director of the Centers 
for Disease Control and Prevention, and the Commissioner of the Food 
and Drug Administration (or the designees of such officials) serve as 
nonvoting ex officio members.
    Specifically, HRSA is requesting nominations for three voting 
members of the ACCV representing: (1) A health professional, who has 
expertise in the health care of children and the epidemiology, 
etiology, and prevention of childhood diseases; (2) a member of the 
general public who is the legal representative (parent or guardian) of 
a child who has suffered a vaccine related injury or death; and (3) an 
attorney with no specific affiliation. Nominees will be invited to 
serve a 3-year term beginning January 1, 2014, and ending December 31, 
2016.
    Interested persons may nominate one or more qualified persons for 
membership on the ACCV. Nominations shall state that the nominee is 
willing to serve as a member of the ACCV and appears to have no 
conflict of interest that would preclude the ACCV membership. Potential 
candidates will be asked to provide detailed information concerning 
consultancies, research grants, or contracts to permit evaluation of 
possible sources of conflicts of interest. A curriculum vitae or resume 
should be submitted with the nomination.
    The Department of Health and Human Services (HHS) strives to ensure 
that the membership of the HHS Federal Advisory Committee is fairly 
balanced in terms of points of view presented and the committee's 
function. Every effort is made to ensure that the views of women, all 
ethnic and racial groups, and people with disabilities are represented 
on HHS Federal Advisory Committees and, therefore, the Department 
encourages nominations of qualified candidates from these groups. The 
Department also encourages geographic diversity in the composition of 
the Committee. Appointment to this Committee shall be made without 
discrimination on basis of age, race, ethnicity, gender, sexual 
orientation, disability, and cultural, religious, or socioeconomic 
status.

    Dated: July 3, 2013.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2013-16603 Filed 7-9-13; 8:45 am]
BILLING CODE 4165-15-P